Testing the SurVaxM Vaccine for Lung Cancer Prevention
Testing the SurVaxM Vaccine for Lung Cancer Prevention
Not yet recruiting · NCT07169617 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the SurVaxM Vaccine for Lung Cancer Prevention | Neoplasms by Site, Thoracic Neoplasms, lung carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-08-26 | NCT07169617 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northwestern University | Chicago | United States | 727 |
| Rocky Mountain Regional VA Medical Center | Aurora | United States | 41 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| University of Tennessee - Knoxville | Knoxville | United States | 54 |